IL-15: targeting CD8+ T cells for immunotherapy.

Diab, A; Cohen, A D; Alpdogan, O; Perales, M-A

Diab, A; Cohen, A D; Alpdogan, O; Perales, M-A.

Affiliation

Diab A; Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

Cytotherapy ; 7(1): 23-35, 2005.

Article in En | MEDLINE | ID: mdl-16040381

Subject(s)

CD8-Positive T-Lymphocytes/immunology; Immunotherapy/trends; Interleukin-15/immunology; Lymphocyte Activation/immunology; Animals; CD8-Positive T-Lymphocytes/drug effects; HIV Infections/drug therapy; Humans; Immune System Diseases/drug therapy; Immune System Diseases/immunology; Immunotherapy/methods; Interleukin-15/pharmacology; Interleukin-15/therapeutic use; Killer Cells, Natural/drug effects; Killer Cells, Natural/immunology; Lymphocyte Activation/drug effects; Neoplasms/drug therapy; Neoplasms/immunology; Vaccines/immunology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Lymphocyte Activation / CD8-Positive T-Lymphocytes / Interleukin-15 / Immunotherapy Limits: Animals / Humans Language: En Journal: Cytotherapy Journal subject: TERAPEUTICA Year: 2005 Document type: Article Affiliation country: United States Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links